{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:33:40Z","timestamp":1792773220288,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011542","name":"Mayo Clinic Center for Clinical and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.jcrc.2026.155708","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:06:10Z","timestamp":1786604770000},"page":"155708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Early hemodynamic response to angiotensin II defines a prognostic phenotype in bloodstream infection\u2013associated septic shock"],"prefix":"10.1016","volume":"97","author":[{"given":"Georges","family":"Khattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kealy","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiloh","family":"Danley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cartin-Ceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Skolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8225-1361","authenticated-orcid":false,"given":"Aaron M.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcrc.2026.155708_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155708_bb0010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.jcrc.2026.155708_bb0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jcrc.2026.155708_bb0020","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jcrc.2026.155708_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155708_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: vasopressin in the management of septic shock","volume":"15","author":"Russell","year":"2011","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155708_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-024-05123-7","article-title":"The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II","volume":"28","author":"Legrand","year":"2024","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-025-05311-z","article-title":"An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock","volume":"29","author":"Leisman","year":"2025","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155708_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"4","key":"10.1016\/j.jcrc.2026.155708_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155708_bb0080","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/01.CCM.0000215112.84523.F0","article-title":"Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today\u2019s critically ill patients","volume":"34","author":"Zimmerman","year":"2006","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann. Intensive Care"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155708_bb0090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a Multicenter study of Postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A Multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J. Intensive Care Med."},{"issue":"9","key":"10.1016\/j.jcrc.2026.155708_bb0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2026.155708_bb0105","article-title":"Effectiveness of angiotensin II for catecholamine refractory septic or distributive shock on mortality: a propensity score weighted analysis of real-world experience in the medical ICU","volume":"4","author":"Quan","year":"2022","journal-title":"Crit Care Explor."},{"issue":"2","key":"10.1016\/j.jcrc.2026.155708_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SHK.0000000000002384","article-title":"Angiotensin ii in the treatment of distributive shock: a systematic-review and Meta-analysis","volume":"62","author":"Xourgia","year":"2024","journal-title":"Shock"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126002868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126002868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:35:34Z","timestamp":1792766134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944126002868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":22,"alternative-id":["S0883944126002868"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155708","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early hemodynamic response to angiotensin II defines a prognostic phenotype in bloodstream infection\u2013associated septic shock","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155708"}}